An Attenuated Strain of Enterovirus 71 Belonging to Genotype A Showed a Broad Spectrum of Antigenicity with Attenuated Neurovirulence in Cynomolgus Monkeys

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Virology

• Publication date

  2007-06-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.02856-06PMID 17567701PMCID PMC1951441
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Viral Pathogenesis

  2020cited by this paper
• Rational Design of Genetically Stable, Live-Attenuated Poliovirus Vaccines of All Three Serotypes: Relevance to Poliomyelitis Eradication

  2006cited by this paper
• Reduction of the Rate of Poliovirus Protein Synthesis through Large-Scale Codon Deoptimization Causes Attenuation of Viral Virulence by Lowering Specific Infectivity

  2006cited by this paper
• Evolution of EV71 genogroup in Taiwan from 1998 to 2005: An emerging of subgenogroup C4 of EV71

  2006cited by this paper
• Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon.

  2006cited by this paper
• Modulation of Poliovirus Replicative Fitness in HeLa Cells by Deoptimization of Synonymous Codon Usage in the Capsid Region

  2006cited by this paper
• Mutation of a Single Conserved Nucleotide between the Cloverleaf and Internal Ribosome Entry Site Attenuates Poliovirus Neurovirulence

  2005cited by this paper
• Frequent Importation of Enterovirus 71 from Surrounding Countries into the Local Community of Yamagata, Japan, between 1998 and 2003

  2005cited by this paper
• Genetic Characteristics of Human Enterovirus 71 and Coxsackievirus A16 Circulating from 1999 to 2004 in Shenzhen, People's Republic of China

  2005cited by this paper
• Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys.

  2005influential reference
• Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria

  2005cited by this paper
• Virus perpetuation in populations: biological variables that determine persistence or eradication

  2005cited by this paper
• Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation.

  2004cited by this paper
• Characterization of in vitro and in vivo phenotypes of poliovirus type 1 mutants with reduced viral protein synthesis activity.

  2004cited by this paper
• Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region

  2004cited by this paper
• An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi.

  2004cited by this paper
• Comparative studies on the neurovirulence of temperature-sensitive and temperature-resistant viruses of enterovirus 71 in monkeys

  2004cited by this paper
• A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice.

  2004cited by this paper
• Enterovirus 71 Outbreaks, Taiwan: Occurrence and Recognition

  2003cited by this paper
• Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema.

  2003cited by this paper
• Outbreak of Central Nervous System Disease Associated with Hand, Foot, and Mouth Disease in Japan during the Summer of 2000: Detection and Molecular Epidemiology of Enterovirus 71

  2002cited by this paper
• Change of Major Genotype of Enterovirus 71 in Outbreaks of Hand-Foot-and-Mouth Disease in Taiwan between 1998 and 2000

  2002cited by this paper
• Rapid serological diagnosis of enterovirus 71 infection by IgM ELISA.

  2002cited by this paper
• Incidence and case‐fatality rates resulting from the 1998 enterovirus 71 outbreak in Taiwan

  2002cited by this paper
• Pyramidal and extrapyramidal involvement in experimental infection of cynomolgus monkeys with enterovirus 71

  2002influential reference
• An overview of the evolution of enterovirus 71 and its clinical and public health significance.

  2002cited by this paper
• Phylogenetic Analysis of Enterovirus 71 Strains Isolated during Linked Epidemics in Malaysia, Singapore, and Western Australia

  2001cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Molecular Epidemiology and Evolution of Enterovirus 71 Strains Isolated from 1970 to 1998

  1999cited by this paper
• Molecular detection of enteroviruses from an outbreak of hand, foot and mouth disease in Malaysia in 1997.

  1999cited by this paper
• Dual Stem Loops within the Poliovirus Internal Ribosomal Entry Site Control Neurovirulence

  1999cited by this paper
• Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications.

  1999cited by this paper
• Interaction of Poliovirus with Its Receptor Affords a High Level of Infectivity to the Virion in Poliovirus Infections Mediated by the Fc Receptor

  1999cited by this paper
• Outbreak of severe neurologic involvement associated with Enterovirus 71 infection.

  1999cited by this paper
• Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998.

  1999cited by this paper
• Neurologic complications in children with enterovirus 71 infection.

  1999cited by this paper
• Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease.

  1999influential reference
• An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

  1999cited by this paper
• Fatal enterovirus 71 encephalomyelitis.

  1998cited by this paper
• Molecular comparison of coxsackie A virus serotypes.

  1995cited by this paper
• Construction and genetic analysis of dicistronic polioviruses containing open reading frames for epitopes of human immunodeficiency virus type 1 gp120

  1995cited by this paper
• Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus.

  1995influential reference
• A mutation in the RNA polymerase of poliovirus type 1 contributes to attenuation in mice

  1993influential reference
• The molecular biology of poliovaccines.

  1992cited by this paper
• Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome

  1989cited by this paper
• Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype

  1989influential reference
• Genetic analysis of the attenuation phenotype of poliovirus type 1

  1986influential reference
• [An epidemic of hand, foot and mouth disease].

  1984cited by this paper
• PATHOGENICITY OF A POLIOMYELITIS‐LIKE DISEASE IN MONKEYS INFECTED ORALLY WITH ENTEROVIRUS 71: A MODEL FOR HUMAN INFECTION

  1982cited by this paper
• The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance.

  1979cited by this paper
• Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71.

  1979cited by this paper
• Epidemic of hand, foot and mouth disease associated with enterovirus 71 infection.

  1978cited by this paper
• An apparently new enterovirus isolated from patients with disease of the central nervous system.

  1974cited by this paper
• Virus Aggregation as the Cause of the Non-neutralizable Persistent Fraction

  1967cited by this paper
• The antigenic heterogeneity of type 30 echoviruses.

  1967cited by this paper
• Oral poliovirus vaccine. History of its development and prospects for eradication of poliomyelitis.

  1965cited by this paper
• Oral poliovirus vaccine.

  1960cited by this paper
• Pathogenesis of poliomyelitis; reappraisal in the light of new data.

  1956cited by this paper
• Viremia in experimental poliomyelitis. I. General aspects of infection after intravascular inoculation with strains of high and of low invasiveness.

  1954cited by this paper
• Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche

  1931cited by this paper

• Antiviral Activity of Marine Bacterium Paraliobacillus zengyii Against Enterovirus 71 In Vitro and In Vivo

  2025cites this paper
• A New Vaccine Candidate Strain of Coxsackievirus B5 Selected on the Basis of its Biological Properties

  2025cites this paper
• Viral interference during coinfection and sequential infection of enterovirus A71 and coxsackievirus A16.

  2025cites this paper
• Neuroinvasion via Peripheral Nerves in Epidemic Viral Encephalitis Caused by Enterovirus, Orthoflavivirus and SARS‐Coronavirus

  2025cites this paper
• Genotyping and phylogeographic dynamics of coxsackievirus A16

  2024cites this paper
• Understanding neurotropic enteric viruses: routes of infection and mechanisms of attenuation

  2024cites this paper
• The Growing Phenomenon of ‘Frozen’ Virus Genome Sequences and Their Likely Origin in Research Facility Escapes

  2024cites this paper
• Inferring B-cell derived T-cell receptor induced multi-epitope-based vaccine candidate against enterovirus 71: a reverse vaccinology approach

  2024cites this paper
• Inferring B-cell derived T-cell receptor induced multi epitope-based vaccine candidate against enterovirus 71 (EV 71): A reverse vaccinology approach

  2023cites this paper
• Experimental animal models for development of human enterovirus vaccine

  2023cites this paper
• Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD).

  2022cites this paper
• Development of an Enzyme-Linked Immunosorbent Assay for Detection of the Native Conformation of Enterovirus A71

  2022cites this paper
• Does enterovirus 71 urge for effective vaccine control strategies? Challenges and current opinion

  2022cites this paper
• Development of stable, cold-adapted, temperature-sensitive/conditional lethal chimeric enterovirus A71 and coxsackievirus A16

  2022cites this paper
• EV71 was Detected by Real-Time Fluorescence Quantitative RT-PCR Combined with Hand-Foot-Mouth Disease Rhesus Monkey Model

  2022cites this paper
• A novel polypeptide vaccine and Adjuvant Formulation of EV71.

  2021cites this paper
• Enterovirus A71 Vaccines

  2021cites this paper
• Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies

  2021cites this paper
• Coxsackievirus B5 virus-like particle vaccine exhibits greater immunogenicity and immunoprotection than its inactivated counterpart in mice.

  2021cites this paper
• A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans

  2021cites this paper
• Immunization with a fusion protein vaccine candidate generated from truncated peptides of human enterovirus 71 protects mice from lethal enterovirus 71 infections

  2020cites this paper
• ELUCIDATING THE VIRAL AND CELLULAR COMPONENTS OF STRAIN-SPECIFIC ENTEROVIRUS D68 TEMPERATURE SENSITIVITY

  2020cites this paper
• Rational Design of a Replication-Competent and Inheritable Magnetic Viruses for Targeting Biomedical Applications.

  2020cites this paper
• Amino acid substitutions in VP2, VP1, and 2C attenuate a Coxsackievirus A16 in mice.

  2020cites this paper
• Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo

  2019cites this paper
• Longitudinal epidemiology of viral infectious diseases combining virus isolation, antigenic analysis and phylogenetic analysis as well as seroepidemiology in Yamagata, Japan between 1999 and 2018.

  2019cites this paper
• Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease

  2019cites this paper
• Antivirals and vaccines for Enterovirus A71

  2019cites this paper
• Immune responses against enterovirus A71 infection: Implications for vaccine success

  2019cites this paper
• A Novel Murine Model Expressing a Chimeric mSCARB2/hSCARB2 Receptor Is Highly Susceptible to Oral Infection with Clinical Isolates of Enterovirus 71

  2019cites this paper
• Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate

  2019cites this paper
• An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages.

  2019cites this paper
• Insights into innate and adaptive immune responses in vaccine development against EV-A71

  2019cites this paper
• Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection

  2019cites this paper
• Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys

  2018cites this paper
• Sequence analysis‐based characterization and identification of neurovirulence‐associated variants of 36 EV71 strains from China

  2018cites this paper
• Biomineralization State of Viruses and Their Biological Potential.

  2018cites this paper
• VP1 Amino Acid Residue 145 of Enterovirus 71 Is a Key Residue for Its Receptor Attachment and Resistance to Neutralizing Antibody during Cynomolgus Monkey Infection

  2018cites this paper
• Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development

  2018cites this paper
• Inactivated enterovirus 71 with poly-γ-glutamic acid/Chitosan nano particles (PC NPs) induces high cellular and humoral immune responses in BALB/c mice

  2018cites this paper
• Characterization of human enterovirus71 virus-like particles used for vaccine antigens

  2017cites this paper
• AIM2 Inflammasome-Mediated Pyroptosis in Enterovirus A71-Infected Neuronal Cells Restricts Viral Replication

  2017cites this paper
• Human picornaviruses associated with neurological diseases and their neutralization by antibodies.

  2017cites this paper
• Development of Novel miRNA-based Vaccines and Antivirals against Enterovirus 71.

  2017cites this paper
• Characterization of significant molecular determinants of virulence of Enterovirus 71 sub-genotype B4 in Rhabdomyosarcoma cells.

  2017cites this paper
• A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitro

  2017cites this paper
• Enterovirus 71 infection and vaccines

  2017cites this paper
• Immunopathogenesis and Virus–Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease

  2017cites this paper
• RSAD2 and AIM2 Modulate Coxsackievirus A16 and Enterovirus A71 Replication in Neuronal Cells in Different Ways That May Be Associated with Their 5′ Nontranslated Regions

  2017cites this paper
• Condition and Prospects of Development of Vaccines for Specific Prevention of Enterovirus (Nonpolio) Infection

  2016cites this paper
• EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases

  2016cites this paper
• EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge

  2016cites this paper
• Enteroviruses in the early 21st century: new manifestations and challenges

  2016cites this paper
• Identification of molecular determinants of cell culture growth characteristics of Enterovirus 71

  2016cites this paper
• Epidemiology and dynamic of hand, foot and mouth disease in Vietnam

  2016cites this paper
• Novel miRNA-based Vaccines and Antivirals against Enterovirus 71 Running Title : miRNA-based Vaccines and Antivirals

  2016cites this paper
• Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain)

  2016cites this paper
• Seroepidemiology and characterisation of neutralisation escape mutants of enterovirus A71 / Nik Nadia Nik Mohd Nasir

  2016cites this paper
• Characterization of the adaptive immune responses in enterovirus a71 infection / Aw Yong Kam Leng

  2016cites this paper
• Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection.

  2015cites this paper
• The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model

  2015cites this paper
• Sukcesor wirusa polio - enterowirus 71

  2015cites this paper
• The epidemiology of non-polio enteroviruses: recent advances and outstanding questions

  2015cites this paper
• Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses

  2015cites this paper
• Therapeutic and prevention strategies against human enterovirus 71 infection.

  2015cites this paper
• Attenuation of virulence as antimicrobial strategy

  2015cites this paper
• Immunity and clinical efficacy of an inactivated enterovirus 71 vaccine in healthy Chinese children: a report of further observations

  2015cites this paper
• Development of Novel Vaccines against Enterovirus-71

  2015cites this paper
• Molecular epidemiology and evolution of human enterovirus 71 and hand, foot and mouth disease.

  2015cites this paper
• Elucidating the host-pathogen interactions between in vitro human cells and enterovirus 71 in Hand, Foot and Mouth Disease (HFMD)

  2015cites this paper
• Towards broadly protective polyvalent vaccines against hand, foot and mouth disease.

  2015cites this paper
• Rational design of live attenuated vaccine by site-directed mutagenesis and deletion in the 5’- non coding region of the enterovirus 71(EV-A71) genome

  2015cites this paper
• Cryo-Electron Microscopy Study of Insect Cell-Expressed Enterovirus 71 and Coxsackievirus A16 Virus-Like Particles Provides a Structural Basis for Vaccine Development

  2014cites this paper
• Analysis of Cross-Reactive Neutralizing Antibodies in Human HFMD Serum with an EV71 Pseudovirus-Based Assay

  2014cites this paper
• Virus-like particles in picornavirus vaccine development

  2014cites this paper
• Monitoring Antigenic Variations of Enterovirus 71: Implications for Virus Surveillance and Vaccine Development

  2014cites this paper
• EVALUATION OF THE PROTECTIVE EFFICACY OF HIV-1 PROTEASE INHIBITORS AGAINST ENTEROVIRUS 71 INFECTION IN VITRO

  2014cites this paper
• Animal models of enterovirus 71 infection: applications and limitations

  2014cites this paper
• Molecular epidemiology of enterovirus 71 strains isolated from children in Yamagata, Japan, between 1990 and 2013.

  2014cites this paper
• Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques

  2014influential citation
• Cryo-EM study of insect cell-expressed Enterovirus 71 and 1 Coxsackievirus A 16 virus-like particles provides a structural 2 basis for vaccine development

  2014cites this paper
• Cell and tissue tropism of enterovirus 71 and other enteroviruses infections

  2014cites this paper
• Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials

  2014cites this paper
• Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice

  2014cites this paper
• Update on the development of enterovirus 71 vaccines

  2014influential citation
• Coxsackievirus A16 virus-like particles provides a structural

  2014cites this paper
• The Cross-Neutralizing Activity of Enterovirus 71 Subgenotype C4 Vaccines in Healthy Chinese Infants and Children

  2013cites this paper
• Necrotizing myositis causes restrictive hypoventilation in a mouse model for human enterovirus 71 infection

  2013cites this paper
• The molecular basis of mouse adaptation and virulence by human enterovirus 71

  2013cites this paper
• Cross-reactive Neutralizing Antibody Responses to Enterovirus 71 Infections in Young Children: Implications for Vaccine Development

  2013cites this paper
• Progress on the research and development of inactivated EV71 whole-virus vaccines

  2013cites this paper
• Quantification of viral infection dynamics in animal experiments

  2013cites this paper
• Rational design of thermostable vaccines by engineered peptide-induced virus self-biomineralization under physiological conditions

  2013cites this paper
• [Experimental studies on infant Tupaia belangeri chineses with EV71 infection].

  2013cites this paper
• Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine

  2013cites this paper
• Progress on the research and development of human enterovirus 71 (EV71) vaccines

  2013influential citation
• Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.

  2013cites this paper
• Picornavirus and enterovirus diversity with associated human diseases.

  2013cites this paper
• Site-directed in vitro mutagenesis of Enterovirus EV71: implications for the development of an attenuated EV71 vaccine

  2013cites this paper
• Progress on the research and development of EV71 vaccine

  2013cites this paper